Home › Trial NCT06414902
18F-AraG PET/CT as a Non-Invasive Imaging Biomarker for Chemoradiation Treatment Response in Esophageal Cancer
- Trial IDNCT06414902
- StatusRecruiting
- PhasePhase 1
- Study typeInterventional
- SponsorM.D. Anderson Cancer Center
- Enrollment60
- Start date2024-09-04
- ConditionsEsophageal Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.